Advertisement
Clinical Research|Articles in Press

Retrospective analysis of carotid body tumor surgical management: roles of preoperative image investigation and preoperative embolization

  • Author Footnotes
    e Jinsong Wang and Yonghui Li contributed equally to this paper.
    Jinsong Wang
    Footnotes
    e Jinsong Wang and Yonghui Li contributed equally to this paper.
    Affiliations
    Division of Vascular Surgery, National-Guangdong Joint Engineering Laboratory for Diagnosis and Treatment of Vascular Diseases, the First Affiliated Hospital of Sun Yat-sen University, 58 Zhongshan Road 2, Guangzhou 510080, China

    Department of Vascular Surgery, Guangdong Provincial People’s Hospital, 106 ZhongShan Road 2, Guangzhou 510080, China
    Search for articles by this author
  • Author Footnotes
    e Jinsong Wang and Yonghui Li contributed equally to this paper.
    Yonghui Li
    Footnotes
    e Jinsong Wang and Yonghui Li contributed equally to this paper.
    Affiliations
    Division of Cardiovascular Surgery, the Sun Yat-sen Memorial Hospital of Sun Yat-sen University, 107 Yanjiangxi Road, Guangzhou 510080, China
    Search for articles by this author
  • Jin Cui
    Affiliations
    Division of Vascular Surgery, National-Guangdong Joint Engineering Laboratory for Diagnosis and Treatment of Vascular Diseases, the First Affiliated Hospital of Sun Yat-sen University, 58 Zhongshan Road 2, Guangzhou 510080, China
    Search for articles by this author
  • Songqi Li
    Affiliations
    Division of Vascular Surgery, National-Guangdong Joint Engineering Laboratory for Diagnosis and Treatment of Vascular Diseases, the First Affiliated Hospital of Sun Yat-sen University, 58 Zhongshan Road 2, Guangzhou 510080, China

    Department of Breast and Thyroid Surgery, the First Affiliated Hospital of Sun Yat-sen University, 58 Zhongshan Road 2, Guangzhou 510080, China
    Search for articles by this author
  • Weiming Lv
    Affiliations
    Division of Vascular Surgery, National-Guangdong Joint Engineering Laboratory for Diagnosis and Treatment of Vascular Diseases, the First Affiliated Hospital of Sun Yat-sen University, 58 Zhongshan Road 2, Guangzhou 510080, China

    Department of Breast and Thyroid Surgery, the First Affiliated Hospital of Sun Yat-sen University, 58 Zhongshan Road 2, Guangzhou 510080, China
    Search for articles by this author
  • Chen Yao
    Affiliations
    Division of Vascular Surgery, National-Guangdong Joint Engineering Laboratory for Diagnosis and Treatment of Vascular Diseases, the First Affiliated Hospital of Sun Yat-sen University, 58 Zhongshan Road 2, Guangzhou 510080, China
    Search for articles by this author
  • Author Footnotes
    f Shenming Wang is a corresponding author.
    Shenming Wang
    Correspondence
    Corresponding Author : Shenming Wang, MD, PhD. Division of Vascular Surgery, National-Guangdong Joint Engineering Laboratory for Diagnosis and Treatment of Vascular Diseases, the First Affiliated Hospital of Sun Yat-sen University, 58 Zhongshan Road 2, Guangzhou 510080, China. Tel No: +86 20 87755766x8198. Fax: +86 20 87335886. .
    Footnotes
    f Shenming Wang is a corresponding author.
    Affiliations
    Division of Vascular Surgery, National-Guangdong Joint Engineering Laboratory for Diagnosis and Treatment of Vascular Diseases, the First Affiliated Hospital of Sun Yat-sen University, 58 Zhongshan Road 2, Guangzhou 510080, China
    Search for articles by this author
  • Author Footnotes
    e Jinsong Wang and Yonghui Li contributed equally to this paper.
    f Shenming Wang is a corresponding author.
Published:February 28, 2023DOI:https://doi.org/10.1016/j.avsg.2023.02.022

      Abstract

      Objective

      To analyze the management of carotid body tumors (CBTs), particularly the use of preoperative embolization (EMB) and image features in minimizing surgical complications.

      Background

      CBT surgery is a challenging procedure, and the role of EMB in CBT surgery has remained unclear.

      Methods

      A total of 200 CBTs were identified among 184 medical records involving CBT surgery. Regression analysis was used to explore the prognostic predictors of cranial nerve deficit (CND), including image features. In addition, blood loss, operation times, and complication rates were compared between patients who had surgery only versus patients who had surgery along with preoperative EMB.

      Results

      Overall, 96 males and 88 females were identified for inclusion in the study, with a median age of 37.0 years. Computed tomography angiography (CTA) showed the presence of a tiny gap adjacent to the encasement of carotid vessels, which could help minimize carotid arterial injury. High-lying tumors that encased the cranial nerve were usually managed with synchronous cranial nerve resection. Regression analysis revealed that the incidence of CND was positively associated with Shamblin Ⅲ, high-lying, and a maximal CBT diameter of ≥ 5cm. Among 146 EMB cases, two cases of intracranial arterial embolization occurred. No statistical difference was found between the EBM and Non-EBM groups in terms of bleeding volume, operation time, blood loss, blood transfusion requirement, stroke, and permanent CND. Subgroup analysis revealed that EMB decreased CND in Shamblin III and low-lying tumors.

      Conclusions

      CBT surgery should be performed with preoperative CTA to identify favorable factors for minimizing surgical complications. Shamblin Ⅲ or high-lying tumors, as well as CBT diameter, are predictors of permanent CND. EBM does not reduce blood loss or shorten operation time.

      Key words

      Introduction

      Carotid body tumors (CBTs) are the most common among the head-and-neck paragangliomas that develop at the carotid bifurcation, with an incidence < 1:30,000 in the general population.(
      • Sajid MS
      • Hamilton G
      • Baker DM
      Joint Vascular Research Group
      A multicenter review of carotid body tumor management.
      ) CBTs may be associated with nerve-compressive symptoms when their surroundings are invaded.(
      • Economopoulos KP
      • Tzani A
      • Reifsnyder T
      Adjunct endovascular interventions in carotid body tumors.
      ) Slow-developing and often asymptomatic in nature, CBTs have been placed by the World Health Organization Classification of Head and Neck Tumors on a spectrum of metastatic potential(
      • Slootweg PJ
      • El-Naggar AK
      World Health Organization 4th edition of head and neck tumor classification: insight into the consequential modifications.
      ), with early surgical intervention recommended if the patient is of acceptable operative risk.
      CBT surgery has remained a challenging procedure due to the abundant vascularity of the tumor and its contiguity to the internal carotid artery and cranial nerves.(
      • Ma D
      • Liu L
      • Yao H
      • et al.
      A retrospective study in management of carotid body tumour.
      ) In particular, surgical expertise and comprehensive preoperative management are critical in cases where carotid arteries are completely encased. Therefore, preoperative embolization (EMB) has been developed to ensure that complications are minimized. Several early studies have suggested that this procedure could decrease blood loss, shorten operation times, and even reduce neurologic complications.
      • Economopoulos KP
      • Tzani A
      • Reifsnyder T
      Adjunct endovascular interventions in carotid body tumors.
      ,
      • Power AH
      • Bower TC
      • Kasperbauer J
      • et al.
      Impact of preoperative embolization on outcomes of carotid body tumor resections.
      ,
      • Sen I
      • Stephen E
      • Malepathi K
      • et al.
      Neurological complications in carotid body tumors: a 6-year single-center experience.
      However, recent studies question the neurologically stabilizing benefit of EMBs and their necessity in CBT resection.(
      • Abu-Ghanem S
      • Yehuda M
      • Carmel NN
      • et al.
      Impact of preoperative embolization on the outcomes of carotid body tumor surgery: a meta-analysis and review of the literature.
      ) Given the rarity of CBTs, preoperative EMB for CBT surgery remains a relatively novel approach.
      In the past decade, an increasing number of CBT patients have undergone surgical resections, with a substantial proportion accepting preoperative EMB. Thus, this study was designed to review one hospital’s experiences with CBT surgery and compare the clinical outcomes between surgery alone and surgery with preoperative EMB.

      Methods

      Data collection

      The Institutional Review Board of the First Affiliated Hospital of Sun Yat-sen University approved this retrospective study. Cases were identified from medical records spanning from May 1990 to December 2020 at the Division of Vascular Surgery, the First Affiliated Hospital of Sun Yat-sen University. CBT diagnostic criteria included clinical manifestations, preoperative imaging features, digital subtraction angiography, and histology. In addition, demographics, clinical presentations, co-morbidities, tumor characteristics, imaging reports, operative notes, pathologies, and follow-ups were tabulated.

      Definition of variables

      The Shamblin classification
      • Shamblin WR
      • ReMine WH
      • Sheps SG
      • et al.
      Carotid body tumor (chemodectoma). Clinicopathologic analysis of ninety cases.
      ,
      • Gad A
      • Sayed A
      • Elwan H
      • et al.
      Carotid body tumors: a review of 25 years experiences in diagnosis and management of 56 tumors.
      , which assesses the relationship between CBTs and carotid vessels, was applied in this study. Tumors located above the second cervical vertebra were defined as “high-lying”; otherwise, tumors were considered to be “low-lying.” Tumor diameters were measured with preoperative CT scans. Postoperative cranial nerve deficit syndrome (CND), including transient and permanent CND, was defined as transient if resolved at a three-month follow-up. Recurrent loco-regional tumors were paraphrased as “Recurrence.” Paragangliomas originating from the vagal nerve were excluded from this study. Technical success was defined as a significant reduction in tumor blood supply (≥70%) and was independently evaluated by interventional radiologists after EMB.

      Groups

      Since 1996, arteriography was usually performed in CBTs with a maximal diameter ≥3 cm. All participants were divided into EMB and non-EMB groups. The criteria for the decision to perform EMB were as follows: (
      • Sajid MS
      • Hamilton G
      • Baker DM
      Joint Vascular Research Group
      A multicenter review of carotid body tumor management.
      ). Arteriography revealed that tumors had robust feeding arteries and abundant blood supply. (
      • Economopoulos KP
      • Tzani A
      • Reifsnyder T
      Adjunct endovascular interventions in carotid body tumors.
      ). Arteriography indicated a low risk of intracranial embolization (feeding arteries did not anastomose with the intracranial circulation). (
      • Slootweg PJ
      • El-Naggar AK
      World Health Organization 4th edition of head and neck tumor classification: insight into the consequential modifications.
      ). Patients were willing to accept EMB.

      Preoperative examination

      Patients with clinical suspicion of CBT underwent cranial and carotid CTA. CTA was used to define the tumor’s size, location, Shamblin classification, and infiltration of neighboring tissues and local lymph nodes. A tiny space represented low-density and well-defined tumor boundary was also identified on CTA. The tiny space between the tumor and the artery by the cross-section surrounding the CBT (Fig. 1a, Illustrated) indicated that the tumor did not invade the arterial wall and thus was able to be resected without arterial compromise. On the other hand, absence of the tiny space (Fig.1b, Illustrated) indicated arterial invasion, which meant that arterial reconstruction would follow. Patency of the Circle of Willis was preoperatively evaluated using intracranial and carotid arterial CTA in all patients, especially for Shamblin Ⅲ tumors. Endocrine examinations were not routinely performed unless there was a co-existing pheochromocytoma. Positron emission tomography was reserved for malignant tumors.
      Figure thumbnail gr1
      Figure 1The value of preoperative CTA in evaluating whether a tumor invaded nearby arteries. a) The tiny space between the tumor and the artery by the cross-section along the whole tumor (arrow) indicates that the tumor did not invade the artery wall, meaning the tumor could be resected without arterial injury. b) If there is no space between the tumor and the artery (arrow), it means the tumor invaded the artery and that reestablishing the artery should be meticulously planned.

      Neurological system examination

      The recurrent laryngeal nerve was evaluated through vibration of the vocal cord on indirect laryngoscopy by an otolaryngologist. Two on-duty neurologists performed pre- and postoperative examinations to detect neurological deficits. Head CT scans were used to confirm suspected cerebral infarctions.

      Preoperative embolization

      EMB was generally performed under local anesthesia with transfemoral arterial access. Selective angiographic imaging of the internal, external, and common carotid arteries was used to identify the feeding arteries to ensure patency of the Circle of Willis. On angiography, signs of splaying of the carotid vessels and an intense blush in the tumor consolidated the diagnosis of CBT. Selective feeding artery angiographies aimed to delineate the anatomy of the tumor. Embolization was achieved using polyvinyl alcohol (PVA), microspheres, gel foam, and coils based on the characteristics of the feeding arteries. PVA was often used for the tumor vascular bed, and gel foam and coils were utilized for proximal larger branches of the feeding arteries. This study used PVA and gel foam preferentially.

      Surgical resection

      Seven surgeons performed the procedures within 72 hours after EMB. A trans-cervical approach was applied, and the incision curved away from the mandibular angle to avoid injury to the marginal mandibular nerve. The common carotid artery was dissected and exposed, with tumor-feeding branches of the external carotid artery (ECA) ligated, and cranial nerves were preserved. An ECA firmly encased by a large tumor would have to be sacrificed. Any instances of intraoperative ICA injury were repaired with direct closure, patch angioplasty, or great saphenous vein or graft reconstruction. If the carotid artery was clamped due to ICA injury, cerebral perfusion was maintained using the following measures: Systolic blood pressure was raised to 140∼150mmHg or raised by 20∼30mmHg. Heparin was given to achieve a therapeutic activated clotting time (≥200 to 250 seconds). If the Circle of Willis was incomplete or the estimated cross-clamping time was long, then the use of a shunt was compulsory (Table 2). Postoperatively, anticoagulation was initiated for cases requiring a venous graft or prosthetic reconstruction of the ICA. For high-lying CBTs, the mandible bone was disarticulated to facilitate exposure.
      Table 1Demographic characteristics, clinical manifestations and lesion characteristics of the 200 cases of CBT. ( No (%) or median (range))
      VariablesTotal
      Total patients184
      Total CBT resections200
      Male96 (52.2)
      Age, year35 (12 to 67) a
      Clinical manifestations
       Painless tumors195 (97.5)
       Neck pain11(5.5)
       Dizziness or headache12 (6.0)
       Nerve compression symptoms7 (3.5)
      Family history10 (5.4)
      Lesion characteristics
       Bilateral tumor52 (26.0)
       Malignant tumor10 (5.0)
       Size ≥ 5cm84 (42.0)
       High-lying49 (24.5)
       Shamblin I34 (17.0)
       Shamblin II89 (44.5)
       Shamblin III77 (38.5)
      Table 2Intraoperative intervention strategies of 200 cases of carotid body tumor (No. (%))
      VariableTotal
      Resection without ICA reconstruction156 (78.0)
      one patient underwent ICA ligation without reconstruction. CN= cranial nerve
      ICA reconstruction43 (21.5)
       Direct closure/patchplasty21 (10.5)
       Graft reconstruction8 (4.0)
       Vein reconstruction14 (7.0)
      ECA ligation46 (23.0)
      Adjunctive Strategies
       Use of shunt21 (10.5)
       Resection of CN15 (7.5)
      Note: ICA=internal carotid artery; ECA=external carotid artery.
      a one patient underwent ICA ligation without reconstruction. CN= cranial nerve

      Follow-up

      Outpatient visits or telephone follow-ups were performed at three months, one year, and every year with ultrasound and clinical follow-up. These evaluations assessed the recurrence and metastasis of tumors, CND, and stroke, as well as the patency of the target vessels. In addition, CTA was performed in patients with suspected tumor recurrence and at the 1-year follow-up in patients with high-lying tumors or those with ICA reconstruction.

      Statistical analysis

      The continuous variables were expressed as the mean or median and range. In contrast, the categorical variables were recorded as the total number and percentage of patients. Significant inter-variable differences were indicated with a P value < 0.05. Continuous data were analyzed with analysis of variance and categoric variables with χ2 testing. Univariate and multivariable logistic regression models were used to explore the risk factors of CND. Crude estimates were derived from logistic regression models containing only the specified risk factor, while adjusted values from the models included all risk factors. The multivariable model used entry selection to identify risk factors. The entry and removal criteria were set as 0.05 and 0.10, respectively. Odds ratios (ORs) >1 indicated high risks of CND. Subgroup analysis was also performed to further evaluate the role of EMB in different diameters, Shamblin Classifications, and tumor sites.

      Results

      Participants’ demographics and clinical manifestations

      During the study period, the Division of Vascular Surgery diagnosed 202 patients with CBTs, performed 184 surgeries, and resected 200 CBTs (Figure 2).
      Figure thumbnail gr2
      Figure 2Flow chart of patient inclusion in the study
      In total, 96 males and 88 females with a median age of 37.0 years were included in the analysis. The most common symptom was a painless neck mass. Family history was confirmed in 10 (5.0%) patients. Seven (3.5%) patients had an ipsilateral biopsy or an exploratory operation with subsequent surgical resection (Table 1).

      CBT characteristics

      Bilateral CBTs were identified in 52 (26.0%) cases, and multicentric CBTs were found in 2 cases. High-lying CBTs were seen in 49 (24.5%) cases. Thirty-four (17.0%), 89 (44.5%), and 77 (38.5%) cases were classified as Shamblin Group I, Group Ⅱ, and Group Ⅲ, respectively (Table 1). Co-existing pheochromocytoma was found in 1 patient. In addition, 1 patient was associated with vagal paraganglioma originating from the vagus nerve at the level of the cranial base.
      For 10 malignant CBTs, preoperative CTA revealed invasion of neighboring structures and enlarged regional lymph nodes. CBT resection combined with lymph node dissection and histology confirmed regional lymph node metastasis in one case. Three malignant CBTs presented with lung or bone metastasis preoperatively. Five patients who had a total of six CBTs were diagnosed with malignant CBT at follow-up, including three with distant metastasis and three recurrences, which resulted in follow-up radiotherapy.

      Preoperative embolization

      In total, 135 patients who collectively had 148 CBTs underwent EMB. Among them, 142 cases achieved significantly reduced tumor vascularity. There were six treatment failures due to feeding arteries originating from the internal carotid artery or carotid bifurcation. In two different cases, embolization was complicated by hemiplegia and hemianopsia, respectively. Both cases involved Shamblin Ⅱ tumors embolized with polyvinyl alcohol and gel foam. Some symptoms experienced by patients persisted at follow-up. Two patients experienced allergic reactions, 6 reported headache or dizziness, and 3 contracted a fever that cleared after medical treatment.

      Surgical treatment

      Shamblin Ⅰ and Ⅱ tumors were dissected from the ICA using bipolar forceps. Altogether, 10 instances of intraoperative ICA injuries occurred in these dissection cases. Shamblin Ⅲ tumor resections were more vulnerable to ICA injuries (P<0.001), with 33 cases of injury documented. All injured ICAs were successfully repaired except for one injured ICA, which was ligated due to extreme adhesion from a previous operation. Systolic stump pressure of the carotid artery in this patient was 65mmHg. The patient recovered without a stroke.
      A shunt was applied in 21 cases of patients undergoing graft replacement for ICA rupture, which accounted for 48.8% of cases of ICA reconstruction. Seven patients with high-lying CBTs involving the base of the skull underwent resection by mandibular subluxation or disarticulation approach. No complications were encountered using this approach. In 15 cases undergoing both CBT and cranial nerve resections (Table 2), high-lying CBTs were identified in 10 cases (20.4% vs. 3.3%, P<0.001).

      Genetic screening

      In total, 58 patients consented to undergoing genetic tests between 2011 and 2017. SDH mutations were identified in 22 patients, including 4 SDHB, 14 SDHD, and 4 SDHAF2.

      In-hospital and follow-up outcomes

      Postoperative neurologic complications included four strokes, one transient ischemic attack, and 62 CNDs. All four of the patients who had 2 Shamblin Ⅱ and 2 Shamblin Ⅲ CBTs underwent EBM. Strokes manifested as hemiplegia, with one as glossolalia. At follow-ups after rehabilitation, all patients returned to normal activity with mild weakness.
      Eight patients did not complete the follow up, and one patient died during the 28-month follow-up of postoperative CND. There were 34 transient CNDs and 28 permanent CNDs. There were also 5 ICA occlusions for reconstruction, including two ICA reconstructions with great saphenous veins and three with artificial grafts. However, none of these patients developed a stroke (Table 3).
      Table 3In-hospital and follow-up results of CBTs resection. (No. (%) or median (range))
      VariablesTotal
      In-hospital outcomes
      Residual tumor8 (4.0)
      Incision infection4 (2.0)
      Pneumonia8 (4.0)
      Stroke4 (2.0)
      TIA2 (1.0)
      Postoperative nerve deficitc62 (31.0)
       VII8 (4.0)
       IX11 (5.5)
       X41 (20.5)
       XII31 (15.5)
       Superior laryngeal2 (1.0)
       Sympathetic nerve6 (3.0)
      Follow-up outcomes
      Length, months26.5 (3 to 182)
      Median,
      Lost to follow up10 (5.0)
      Death1 (0.5)
      the patient died of lung cancer. TIA= transient ischemic attacks. In
      Recurrent tumor1(0.5)
      Target vessel occlusion5 (2.5)
       Autogenous vessel2 (16.7
      Only those patients accepted ICA replacement with autogenous vessel were considered.
      )
       Artificial graft3 (37.5
      Only those patients experienced ICA replacement with artificial graft were considered
      )
      Permanent nerve deficit
      Two or more nerve might be injuried in one patient.
      28 (14.0)
       VII5 (2.5)
       X15 (7.5)
       XII12 (6.0)
       Superior laryngeal3 (1.5)
       Sympathetic nerve2(1.0)
      a Median,
      b the patient died of lung cancer. TIA= transient ischemic attacks. In
      c Two or more nerve might be injuried in one patient.
      d Only those patients accepted ICA replacement with autogenous vessel were considered.
      e Only those patients experienced ICA replacement with artificial graft were considered

      Predictors of transient CND

      In the univariate logistic model, CBTs classified as high-lying (OR=5.185, 95% confidence interval (CI): 2.606-10.318, P<0.001) or Shamblin Ⅲ (OR=3.276, 95% CI: 1.757- 6.106, P<0.001), as well as tumors with a diameter ≥5 cm (OR=2.769, 95% CI: 1.495- 5.128, P=0.001), carried higher risks of postoperative CND.
      In multivariable regression analysis, CBTs classified as high-lying (OR=3.398, 95% CI: 1.563-7.383, P=0.002) were associated with higher risks of postoperative CND (Table 4).
      Table 4Risk factors of cranial nerve deficit following surgical resection
      Risk factorsCrudeAdjusted
      OR95%CIP valueOR95%CIP value
      Postoperative cranial nerve deficit
      Bilateral1.112(0.565, 2.188)0.7591.127(0.510, 2.492)0.767
      Malignant0.952(0.238, 3.809)0.9440.759(0.163, 3.522)0.724
      Diameter≥5cm2.769(1.495, 5.128)0.0011.868(0.913, 3.820)0.087
      High-lying5.185(2.606, 10.318)<0.0013.398(1.563, 7.383)0.002
      Shamblin III3.276(1.757,6.106)<0.0011.851(0.915, 3.745)0.087
      Permanent cranial nerve deficit
      Bilateral1.720(0.737, 4.014)0.2102.355(0.781, 7.097)0.128
      Malignant1.577(0.317, 8.840)0.5781.238(0.196, 7.828)0.821
      Diameter≥5cm4.435(1.845, 10.662)0.0013.586(1.204, 10.687)0.022
      High-lying9.993(4.122, 22.224)<0.0014.773(1.808, 12.595)0.002
      Shamblin III6.214(2.494, 15.483)<0.0012.893(1.045, 8.006)0.041
      Note: Crude estimates are from logistic regression models containing only the specified risk factor. Adjusted values are from logistic regression models including all risk factors.

      Predictors of permanent CND

      In univariate logistic regression analysis, tumors with a diameter ≥5 cm (OR=4.435, 95% CI: 1.845-10.662, P=0.001), as well as those classified as high-lying (OR =9.993, 95% CI: 4.122-22.224, P<0.001) or Shamblin Ⅲ (OR =6.214, 95% CI: 2.494 -15.483, P<0.001), were associated with higher risks of permanent CND.
      In multivariable logistic regression analysis, a maximal diameter≥5 cm (OR=3.586, 95% CI: 1.204-10.687, P=0.022), as well as tumors classified as high-lying (OR=4.773, 95% CI: 1.808-12.595, P=0.002) or Shamblin Ⅲ (OR=2.893, 95% CI: 1.045-8.006, P=0.041), were effective predictors of permanent CND (Table 4).

      Comparison of outcomes

      More CBTs with EMB presented as high-lying (30.8% vs 7.4%, P =0.001) and Shamblin Ⅲ (43.2% vs 25.9%, P =0.026) tumors compared to tumors without EMB.
      EMB was not found to decrease rates of postoperative CND (28.8% vs 37.0%, P = 0.262), permanent CND (13.7 %vs 14.8%, P =0.840), or stroke (2.7 % vs 0%, P =0.576). Similarly, EMB did not significantly decrease blood loss ( 100 ml vs 100.0 ml, P =0.320), blood transfusion, or operation time (180 min vs 170.0 min, P =0.280) (Table 5).
      Table 5Comparison outcome between the preoperative embolism group and the non-preoperative embolism group. (No. (%) or median (range))
      VariablesEMB groupNon-EMB groupP value
      the level of significant difference was determined by Χ2test, continuity correction or Fisher test accordingly.
      Total patients13549
      Total tumors146 (73.0)54 (27.0)---
      Male68 (50.4)28 (57.1)0.416
      Age, year35 (12 to 67)36 (21 to 63)0.732
      A Mann-Whitney test was used.
      Family history6 (4.4)4 (7.4)0.538
      Bilateral tumor40 (27.3)12 (22.2)0.459
      Size ≥5cm65 (44.5)19 (35.2)0.235
      High-lying45 (30.8)4 (7.4)0.001
      Shamblin III63 (43.2)14 (25.9)0.026
      ICA reconstruction35 (24.0)8 (14.8)0.162
      Ligation of ECA or its branches35 (24.0)11 (20.4)0.591
      Resection of CN11(7.5)4 (7.4)0.976
      Operation time,min180 (45 to 720)170 (55 to 575)0.280
      A Mann-Whitney test was used.
      Blood loss, ml100 (5 to 6000)100 (5 to 2000)0.320
      A Mann-Whitney test was used.
      Blood transfusion26 (22.4)
      Data on blood transfusion were available in 116 patients in EMB group and 48 patients in non-EMB group
      10 (20.8)
      Data on blood transfusion were available in 116 patients in EMB group and 48 patients in non-EMB group
      0.824
      Stroke4 (2.7)0 (0)0.576
      Postoperative CND42 (28.8)20 (37.0)0.262
      Permanent CND20 (13.7)8 (14.8)0.840
      Note: ICA=internal carotid artery; ECA=external carotid artery. CN= cranial nerve, CND= cranial nerve deficit.
      a the level of significant difference was determined by Χ2test, continuity correction or Fisher test accordingly.
      b A Mann-Whitney test was used.
      c Data on blood transfusion were available in 116 patients in EMB group and 48 patients in non-EMB group

      Subgroup analysis

      In subgroup analysis, EMB was still not found to decrease blood loss, blood transfusion, or operation time regardless of tumor diameter (“ ≥ ” or “ <” 5 cm), Shamblin classification, or tumor site. However, more instances of CND were found in the EMB group when only Shamblin Ⅲ or low-lying tumors were considered (Table 6).
      Table 6Comparison outcome of blood loss, blood transfusion, operation time and cranial nerve defict in different subgroups (No. (%) or median (range)).
      VariablesEMB groupNon-EMB groupP value
      the level of significant difference was determined by Mann-Whitney or χ2 test, continuity correction or Fisher test accordingly.
      Blood loss
       Diameter >=5 cm200(10 to 6000)200 (50 to 2000)0.639
       Diameter <5 cm65 (5 to 800)50 (5 to 1500)0.386
       Shamblin Ⅲ300 (20 to 6000)200 (50 to 2000)0.849
       Shamblin Ⅰ or Ⅱ50 (5 to 500)75 (5 to 800)0.933
       High-lying300 (20 to 6000)636 (50 to 800)0.428
       Low-lying100 (5 to 1500)100( 5 to 2000)0.821
      Blood Transfusion
       Diameter >=5 cm19 (29.2)4 (23.5)0.871
       Diameter <5 cm7 (8.6)6 (16.2)0.367
       Shamblin Ⅲ20 (31.7)4 (28.6)1.000
       Shamblin Ⅰ or Ⅱ6 (7.2)6 (15.0)0.300
       High-lying12 (26.7)2 (50.0)0.568
       Low-lying14 (13.9)8 (16.0)0.726
      Operation time
       Diameter >=5 cm200 (75 to 720)235 (120 to 390)0.932
       Diameter <5 cm170 (45 to 540)145 (55 to 570)0.407
       Shamblin Ⅲ240 (50 to 720)252.5 (80 to 570)0.920
       Shamblin Ⅰ or Ⅱ167.5 (45 to 540)140 (55 to 345)0.777
       High-lying260 (75 to 720)330 (170 to 570)0.433
       Low-lying167.5 (45 to 378)160 (55 to 390)0.845
      Cranial nerve deficit
       Diameter >=5 cm26 (40.0)10 (58.8)0.164
       Diameter <5 cm16 (19.8)10 (27.0)0.376
       Shamblin Ⅲ26 (41.3)10 (71.4)0.041
       Shamblin Ⅰ or Ⅱ16 (19.3)10 (25)0.466
       High-lying25 (56.8)4 (100.0)0.142
       Low-lying17 (16.8)16 (32)0.034
      a the level of significant difference was determined by Mann-Whitney or χ2 test, continuity correction or Fisher test accordingly.

      Discussion

      CBTs, which are the most common head and neck paraganglioma, are predominantly unilateral tumors. In one meta-analysis involving 4,743 patients, bilateral tumors were only reported in 9.6% of patients. The current study found that 26% of CBTs from the study population were bilateral, while 5.0% of patients had a family history consistent with prior studies.(
      • Robertson V
      • Poli F
      • Hobson B
      • et al.
      A Systematic Review and Meta-Analysis of the Presentation and Surgical Management of Patients with Carotid Body Tumours.
      ) Multicentric paragangliomas are rare,
      • Wieneke JA
      • Smith A
      Paraganglioma: carotid body tumor.
      ,
      • Texakalidis P
      • Charisis N
      • Giannopoulos S
      • et al.
      Role of Preoperative Embolization in Carotid Body Tumor Surgery: A Systematic Review and Meta-Analysis.
      and only two cases in the current cohort were confirmed intraoperatively as vagus paragangliomas asscociated with CBTs. This study suggested the importance of proactively investigating the possible presence of bilateral CBTs when unilateral CBTs are diagnosed.
      CTA can be used to identify the anatomy and vascularity of CBT, thus confirming nearby structural relationships.
      • Liu J
      • Mu H
      • Zhang W
      Diagnosis and treatment of carotid body tumors.
      ,
      • van den Berg R
      Imaging and management of head and neck paragangliomas.
      As shown in Figure 1, CTA with a cross-sectional view could quantitate the tiny space between the CBT and the carotid artery, which could direct CBT dissection without arterial injury (Figure 1). Furthermore, CTA could differentiate other tumors, identify recurrent tumors at follow-up, and assess the patency of the Circle of Willis, which is crucial to predicting stroke risks.
      In this study, CBTs were surgically resected with bilateral CBTs, which required staged removal. Smaller CBTs were resected first to build patient confidence for further resection. For high-lying tumors involving the base of the skull, subluxation or disarticulation of the mandible helped to obtain a clear operation field, especially with regard to the ICA.
      Strokes occurred in 2.0% of patients in this cohort, which is consistent with other studies that reported between 0-8%.
      • Gwon JG
      • Kwon TW
      • Kim H
      • et al.
      Risk factors for stroke during surgery for carotid body tumors.
      ,
      • Dardik A
      • Eisele DW
      • Williams GM
      • et al.
      A contemporary assessment of carotid body tumor surgery.
      ,
      • Paridaans MP
      • van der Bogt KE
      • Jansen JC
      • et al.
      Results from craniocaudal carotid body tumor resection: should it be the standard surgical approach?.
      The cohort also showed three cases of unexpected ICA injury needing urgent clamping for ICA repair. Two strokes were attributed to heparinization failure and pre-procedure hypertension. One stroke was due to an abrupt ICA rupture that occurred postoperatively, which may have resulted from hypertension and the disruption of insufficient arterial intimal suturing. All reconstruction of carotid arteries was free from strokes, highlighting the importance of preoperative planning to reduce ICA injuries and stroke risks, especially for tumors classified as Shamblin III. (
      • Metheetrairut C
      • Chotikavanich C
      • Keskool P
      • et al.
      Carotid body tumor: a 25-year experience.
      )
      In some studies, the ICA could not be dissected from the CBT in 20 to 40% of cases.(
      • Gilbo P
      • Morris CG
      • Amdur RJ
      • et al.
      Radiotherapy for benign head and neck paragangliomas: a 45-year experience.
      ) Minimal ICA defects, usually occurring at the bifurcation, could be repaired by direct suture with 6-0 propylene, while more significant defects would need to be patched or reconstructed.(
      • Davila VJ
      • Chang JM
      • Stone WM
      • et al.
      Current surgical management of carotid body tumors.
      ) Regarding the choice of reconstruction material, there was no consensus as to the optimal reconstructive materials.(
      • Spinelli F
      • Massara M
      • La Spada M
      • et al.
      A simple technique to achieve bloodless excision of carotid body tumors.
      ) The current study reported 2 of 14 autogenous vein occlusions and 3 of 8 graft occlusions at follow-up. The autogenous vein was recommended for young patients and selective reconstruction, while a graft made by polytetrafluoroethylene was applied if a great saphenous vein was unavailable. Anticoagulation or antiplatelet treatment was necessary for long-term patency.
      Shunts were used for reducing stroke risks in seriously damaged ICAs. In the case of abrupt ICA rupture, ICA shunts could shorten brain ischemia time, allowing for complication-free ICA reconstruction. Evidence showed that shunts used in carotid endarterectomy did not reduce stroke risk, owing to plaque shedding during shunt implantation.(
      • Spinelli F
      • Massara M
      • La Spada M
      • et al.
      A simple technique to achieve bloodless excision of carotid body tumors.
      ) The CBT patients in the current study might benefit from the use of shunts due to an overall younger demographic with plaque-free carotid arteries.
      Postoperative CND is the most common complication in surgeries with large,Shamblin Ⅲ CBTs and vagus nerve paragangliomas.
      • Sajid MS
      • Hamilton G
      • Baker DM
      Joint Vascular Research Group
      A multicenter review of carotid body tumor management.
      ,
      • Amato B
      • Bianco T
      • Compagna R
      • et al.
      Surgical resection of carotid body paragangliomas: 10 years of experience.
      ,
      • Straughan DM
      • Neychev VK
      • Sadowski SM
      • et al.
      Preoperative imaging features are associated with surgical complications following carotid body tumor resection.
      In the current study, postoperative CND occurred in 31.0% of patients, with 14.0% resulting in permanent CND. Amato et al. reviewed 19 studies between 2004 to 2014, including 625 CBT surgeries, and CND was observed in 302 (48.3%) cases, including 194 (31.0%) instances of transient and 108 (17.3%) instances of permanent CND.(
      • Amato B
      • Bianco T
      • Compagna R
      • et al.
      Surgical resection of carotid body paragangliomas: 10 years of experience.
      ) It has been widely accepted that the Shamblin classification might be associated with CND and serve as effective predictors of permanent CND.
      • Sajid MS
      • Hamilton G
      • Baker DM
      Joint Vascular Research Group
      A multicenter review of carotid body tumor management.
      ,
      • Amato B
      • Bianco T
      • Compagna R
      • et al.
      Surgical resection of carotid body paragangliomas: 10 years of experience.
      ,
      • Straughan DM
      • Neychev VK
      • Sadowski SM
      • et al.
      Preoperative imaging features are associated with surgical complications following carotid body tumor resection.
      ,
      • Luna-Ortiz K
      • Rascon-Ortiz M
      • Villavicencio-Valencia V
      • et al.
      Carotid body tumors: review of a 20-year experience.
      Straughan et al. found an incidence of CND that was positively associated with a high-lying CBT. (
      • Plukker JT
      • Brongers EP
      • Vermey A
      • et al.
      Outcome of surgical treatment for carotid body paraganglioma.
      ) A multi-center study by Kim et al. demonstrated that tumor proximity to the skull base, as well as tumor volume in combination with the Shamblin classification, could better predict CND risk. (
      • Kim GY
      • Lawrence PF
      • Moridzadeh RS
      • et al.
      New predictors of complications in carotid body tumor resection.
      ) In the current study, high-lying tumors were found to be an independent predictor of permanent CND. High-lying CBTs are subject to limited access, problematic exposure, and extensive incisions, including the mandible, which thus increases operation complexity, blood loss, and operation times. In addition, the facial nerve’s hypoglossal and marginal mandibular branches are compromised with high-lying CBTs, which predisposes patients to CND. In the current cohort, injury of the hypoglossal nerve by high-lying CBTs was the leading cause of permanent CND, which was found to be a better risk predictor of CND than the Shamblin classification system.
      Compared with the non-EMB group, the EMB group did not exhibit a decreased rate of stroke in this cohort, which is consistent with a previous study.(
      • Cobb AN
      • Barkat A
      • Daungjaiboon W
      • et al.
      Carotid Body Tumor Resection: Just as Safe without Preoperative Embolization.
      ) On the contrary, there are inherent risks of stroke, although low, to angiography with and without intervention. In the current study, 2 of 148 cases developed stroke due to embolization in unexpected areas. To prevent strokes, EBM was contraindicated in cases with feeding arteries originating from the ICA or carotid bifurcation, or in cases of having anastomosis with intracranial circulation.
      • Texakalidis P
      • Charisis N
      • Giannopoulos S
      • et al.
      Role of Preoperative Embolization in Carotid Body Tumor Surgery: A Systematic Review and Meta-Analysis.
      ,
      • Tikkakoski T
      • Luotonen J
      • Leinonen S
      • et al.
      Preoperative embolization in the management of neck paragangliomas.
      ,
      • Duffis EJ
      • Gandhi CD
      • Prestigiacomo CJ
      • et al.
      Head, neck, and brain tumor embolization guidelines.
      ,
      • Cavalcanti LM
      • Cruz CB
      • Guedes AJ
      • et al.
      The importance of preoperative embolization for the treatment of the carotid body tumor: case report and review of the literature.
      Consistent with another study, EMB was not found to decrease the rate of CND.27 However, the EMB group tended to have more Shamblin Ⅲ and large CBTs, which may influence the robustness of this conclusion. In subgroup analysis, more CND was found in the non-EMB group when only Shamblin Ⅲ and low-lying tumors were considered, implying that EMB might be suitable for Shamblin Ⅲ and low-lying tumors. That may be explained by Shamblin Ⅰand Ⅱ tumors generally being able to be safely resected, while high-lying tumors, as mentioned above, carry an extremely high risk of CND regardless of EMB.
      Concerning blood loss and operative time, a recent meta-analysis (
      • Texakalidis P
      • Charisis N
      • Giannopoulos S
      • et al.
      Role of Preoperative Embolization in Carotid Body Tumor Surgery: A Systematic Review and Meta-Analysis.
      ) including 1,326 patients reported that EMB patients had significantly lower blood loss and shortened operation times. However, EMB does not decrease blood transfusion requirements or hospital stays. In the current study, EMB neither decreased blood loss nor shortened operative times. Nevertheless, less blood loss was observed when separating the tumors after EMB, consistent with a remarkable decrease in tumor blood supply after EMB. In the subgroup analysis, EMB decreased the incidence of postoperative cranial nerve deficit in Shamblin Ⅲ and low-lying tumors. Thus, we suggest that EMB be planned for Shamblin Ⅲ and low-lying tumors.

      Conclusions

      In conclusion, CBT tumors could be successfully resected with full examinations, preoperative planning, and improved surgical techniques. EMB was not found to decrease blood loss or shorten operation times. However, EMB might be suitable for Shamblin Ⅲ or low–lying tumors. .

      Conflicts of interest

      None.

      Acknowledgements

      This study was partially supported by grants from the National Natural Science Foundation of China (No. 81873813) and the Natural Science Foundation of Guangdong Province (No. 2020A1515011412).

      References

        • Sajid MS
        • Hamilton G
        • Baker DM
        • Joint Vascular Research Group
        A multicenter review of carotid body tumor management.
        Eur J Vasc Endovas. 2007; 34: 127-130
        • Economopoulos KP
        • Tzani A
        • Reifsnyder T
        Adjunct endovascular interventions in carotid body tumors.
        J Vasc Surg. 2015; 61 (91.e2): 1081
        • Slootweg PJ
        • El-Naggar AK
        World Health Organization 4th edition of head and neck tumor classification: insight into the consequential modifications.
        Virchows Arch. 2018; 472: 311-313
        • Ma D
        • Liu L
        • Yao H
        • et al.
        A retrospective study in management of carotid body tumour.
        Br J Oral Maxillofac Surg. 2009; 47: 461-465
        • Power AH
        • Bower TC
        • Kasperbauer J
        • et al.
        Impact of preoperative embolization on outcomes of carotid body tumor resections.
        J Vasc Surg. 2012; 56: 979-989
        • Sen I
        • Stephen E
        • Malepathi K
        • et al.
        Neurological complications in carotid body tumors: a 6-year single-center experience.
        J Vasc Surg. 2013; 57 (8S): 64S
        • Abu-Ghanem S
        • Yehuda M
        • Carmel NN
        • et al.
        Impact of preoperative embolization on the outcomes of carotid body tumor surgery: a meta-analysis and review of the literature.
        Head Neck. 2016; 38: E2386-2394
        • Shamblin WR
        • ReMine WH
        • Sheps SG
        • et al.
        Carotid body tumor (chemodectoma). Clinicopathologic analysis of ninety cases.
        Am J Surg. 1971; 122: 732-739
        • Gad A
        • Sayed A
        • Elwan H
        • et al.
        Carotid body tumors: a review of 25 years experiences in diagnosis and management of 56 tumors.
        Ann Vasc Dis. 2014; 7: 292-299
        • Robertson V
        • Poli F
        • Hobson B
        • et al.
        A Systematic Review and Meta-Analysis of the Presentation and Surgical Management of Patients with Carotid Body Tumours.
        Eur J Vasc Endovasc Surg. 2019; 57: 477-486
        • Wieneke JA
        • Smith A
        Paraganglioma: carotid body tumor.
        Head Neck Pathol. 2009; 3: 303-306
        • Liu J
        • Mu H
        • Zhang W
        Diagnosis and treatment of carotid body tumors.
        Am J Transl Res. 2021; 13: 14121-14132
        • van den Berg R
        Imaging and management of head and neck paragangliomas.
        Eur Radiol. 2005; 15: 1310-1318
        • Gwon JG
        • Kwon TW
        • Kim H
        • et al.
        Risk factors for stroke during surgery for carotid body tumors.
        World J Surg. 2011; 35: 2154-2158
        • Dardik A
        • Eisele DW
        • Williams GM
        • et al.
        A contemporary assessment of carotid body tumor surgery.
        Vasc Endovascular Surg. 2002; 36: 277-283
        • Paridaans MP
        • van der Bogt KE
        • Jansen JC
        • et al.
        Results from craniocaudal carotid body tumor resection: should it be the standard surgical approach?.
        Eur J Vasc Endovas. 2013; 46: 624-629
        • Metheetrairut C
        • Chotikavanich C
        • Keskool P
        • et al.
        Carotid body tumor: a 25-year experience.
        Eur Arch Otorhinolaryngol. 2016; 273: 2171-2179
        • Gilbo P
        • Morris CG
        • Amdur RJ
        • et al.
        Radiotherapy for benign head and neck paragangliomas: a 45-year experience.
        Cancer. 2014; 120: 3738-3743
        • Davila VJ
        • Chang JM
        • Stone WM
        • et al.
        Current surgical management of carotid body tumors.
        J Vasc Surg. 2016; 64: 1703-1710
        • Spinelli F
        • Massara M
        • La Spada M
        • et al.
        A simple technique to achieve bloodless excision of carotid body tumors.
        J Vasc Surg. 2014; 59: 1462-1464
        • Amato B
        • Bianco T
        • Compagna R
        • et al.
        Surgical resection of carotid body paragangliomas: 10 years of experience.
        Am J Surg. 2014; 207: 293-298
        • Straughan DM
        • Neychev VK
        • Sadowski SM
        • et al.
        Preoperative imaging features are associated with surgical complications following carotid body tumor resection.
        World J Surg. 2015; 39: 2084-2089
        • Luna-Ortiz K
        • Rascon-Ortiz M
        • Villavicencio-Valencia V
        • et al.
        Carotid body tumors: review of a 20-year experience.
        Oral Oncol. 2005; 41: 56-61
        • Plukker JT
        • Brongers EP
        • Vermey A
        • et al.
        Outcome of surgical treatment for carotid body paraganglioma.
        Br J Surg. 2001; 88: 1382-1386
        • Kim GY
        • Lawrence PF
        • Moridzadeh RS
        • et al.
        New predictors of complications in carotid body tumor resection.
        J Vasc Surg. 2017; 65: 1673-1679
        • Cobb AN
        • Barkat A
        • Daungjaiboon W
        • et al.
        Carotid Body Tumor Resection: Just as Safe without Preoperative Embolization.
        Ann Vasc Surg. 2018; 46: 54-59
        • Texakalidis P
        • Charisis N
        • Giannopoulos S
        • et al.
        Role of Preoperative Embolization in Carotid Body Tumor Surgery: A Systematic Review and Meta-Analysis.
        World Neurosurg. 2019; 129: 503-513.e2
        • Tikkakoski T
        • Luotonen J
        • Leinonen S
        • et al.
        Preoperative embolization in the management of neck paragangliomas.
        Laryngoscope. 1997; 107: 821-826
        • Duffis EJ
        • Gandhi CD
        • Prestigiacomo CJ
        • et al.
        Head, neck, and brain tumor embolization guidelines.
        J Neurointerv Surg. 2012; 4: 251-255
        • Cavalcanti LM
        • Cruz CB
        • Guedes AJ
        • et al.
        The importance of preoperative embolization for the treatment of the carotid body tumor: case report and review of the literature.
        J Vasc Brasil. 2008; 7: 163-166